histalim.com
HISTALIM will develop its own precision medicine tool named HISTOPROFILE
HISTALIM will develop its own precision medicine tool named HISTOPROFILE… …through a collaborative R&D program of 29 million euros, endorsed by BPIfrance. Describe with high fidelity the tumor immune profile will be soon a major stake for an appropriate care of the patients affected by cancer. This is the promise offered by the precision medicine tool HISTOPROFILE